247 related articles for article (PubMed ID: 33206644)
21. Demographics, clinical characteristics, and outcomes of 27,256 hospitalized COVID-19 patients in Kermanshah Province, Iran: a retrospective one-year cohort study.
Hesni E; Sayad B; Khosravi Shadmani F; Najafi F; Khodarahmi R; Rahimi Z; Bozorgomid A; Sayad N
BMC Infect Dis; 2022 Mar; 22(1):319. PubMed ID: 35361161
[TBL] [Abstract][Full Text] [Related]
22. Geo-epidemiological reporting and spatial clustering of the 10 most prevalent cancers in Iran.
Babaee E; Roshandel G; Olfatifar M; Tehrani-Banihashemi A; Ashaari A; Nojomi M
Geospat Health; 2021 May; 16(1):. PubMed ID: 34000792
[TBL] [Abstract][Full Text] [Related]
23. Analysis of COVID-19 Cases' Spatial Dependence in US Counties Reveals Health Inequalities.
Saffary T; Adegboye OA; Gayawan E; Elfaki F; Kuddus MA; Saffary R
Front Public Health; 2020; 8():579190. PubMed ID: 33282812
[TBL] [Abstract][Full Text] [Related]
24. SARS-CoV-2 Wave Two Surveillance in East Asia and the Pacific: Longitudinal Trend Analysis.
Post LA; Lin JS; Moss CB; Murphy RL; Ison MG; Achenbach CJ; Resnick D; Singh LN; White J; Boctor MJ; Welch SB; Oehmke JF
J Med Internet Res; 2021 Feb; 23(2):e25454. PubMed ID: 33464207
[TBL] [Abstract][Full Text] [Related]
25. COVID-19 modelling in the Caribbean: Spatial and statistical assessments.
Moonsammy S; Oyedotun TDT; Renn-Moonsammy DM; Oyedotun TD
Spat Spatiotemporal Epidemiol; 2021 Jun; 37():100416. PubMed ID: 33980406
[TBL] [Abstract][Full Text] [Related]
26. Epidemic size, trend and spatiotemporal mapping of SARS-CoV-2 using geographical information system in Alborz Province, Iran.
Kabir K; Taherinia A; Ashourloo D; Khosravi A; Karim H; Salehi Shahrabi H; Hedayat Yaghoobi M; Soleimani A; Siami Z; Noorisepehr M; Tajbakhsh R; Maghsoudi MR; Lak M; Mardi P; Nouri B; Mohammadzadeh M; Azimzadeh M; Bakhtiyari M
BMC Infect Dis; 2021 Nov; 21(1):1185. PubMed ID: 34823478
[TBL] [Abstract][Full Text] [Related]
27. Exploring the spatial pattern of animal bites in Iran (2021-2022).
Ayubi E; Shirzadi MR; Amiri B; Pourmozafari J; Faghih Soleimani M; Khosronejad S; Khazaei S
Prev Vet Med; 2023 Dec; 221():106056. PubMed ID: 37939575
[TBL] [Abstract][Full Text] [Related]
28. The Impact of the Social Distancing Policy on COVID-19 Incidence Cases and Deaths in Iran from February 2020 to January 2021: Insights from an Interrupted Time Series Analysis.
Saki M; Ghanbari MK; Behzadifar M; Imani-Nasab MH; Behzadifar M; Azari S; Bakhtiari A; Wu J; Bragazzi NL
Yale J Biol Med; 2021 Mar; 94(1):13-21. PubMed ID: 33795979
[No Abstract] [Full Text] [Related]
29. Effects of government policies and the Nowruz holidays on confirmed COVID-19 cases in Iran: An intervention time series analysis.
Hadianfar A; Yousefi R; Delavary M; Fakoor V; Shakeri MT; Lavallière M
PLoS One; 2021; 16(8):e0256516. PubMed ID: 34411182
[TBL] [Abstract][Full Text] [Related]
30. Spatiotemporal analysis of the morbidity of global Omicron from November 2021 to February 2022.
Liang Y; Gong Z; Guo J; Cheng Q; Yao Z
J Med Virol; 2022 Nov; 94(11):5354-5362. PubMed ID: 35864556
[TBL] [Abstract][Full Text] [Related]
31. Surveillance Metrics of SARS-CoV-2 Transmission in Central Asia: Longitudinal Trend Analysis.
Post LA; Benishay ET; Moss CB; Murphy RL; Achenbach CJ; Ison MG; Resnick D; Singh LN; White J; Chaudhury AS; Boctor MJ; Welch SB; Oehmke JF
J Med Internet Res; 2021 Feb; 23(2):e25799. PubMed ID: 33475513
[TBL] [Abstract][Full Text] [Related]
32. Observations of the global epidemiology of COVID-19 from the prepandemic period using web-based surveillance: a cross-sectional analysis.
Dawood FS; Ricks P; Njie GJ; Daugherty M; Davis W; Fuller JA; Winstead A; McCarron M; Scott LC; Chen D; Blain AE; Moolenaar R; Li C; Popoola A; Jones C; Anantharam P; Olson N; Marston BJ; Bennett SD
Lancet Infect Dis; 2020 Nov; 20(11):1255-1262. PubMed ID: 32738203
[TBL] [Abstract][Full Text] [Related]
33. Bayesian spatial analysis of age differences and geographical variations in illicit-drug-related mortality in the Islamic Republic of Iran.
Rostami M; Jalilian A; Ghadirzadeh MR; Nazparvar B; Rezaei-Zangeneh R; Karamouzian M
East Mediterr Health J; 2023 Jan; 29(1):24-32. PubMed ID: 36710611
[TBL] [Abstract][Full Text] [Related]
34. The Relationship Between Population-Level SARS-CoV-2 Cycle Threshold Values and Trend of COVID-19 Infection: Longitudinal Study.
Dehesh P; Baradaran HR; Eshrati B; Motevalian SA; Salehi M; Donyavi T
JMIR Public Health Surveill; 2022 Nov; 8(11):e36424. PubMed ID: 36240022
[TBL] [Abstract][Full Text] [Related]
35. Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis.
COVID-19 Forecasting Team
Lancet; 2022 Apr; 399(10334):1469-1488. PubMed ID: 35219376
[TBL] [Abstract][Full Text] [Related]
36. Evaluating prediction of COVID-19 at provincial level of South Africa: a statistical perspective.
Arashi M; Bekker A; Salehi M; Millard S; Botha T; Golpaygani M
Environ Sci Pollut Res Int; 2022 Mar; 29(15):21289-21302. PubMed ID: 34751879
[TBL] [Abstract][Full Text] [Related]
37. Classification of weekly provincial overall age- and gender-specific mortality patterns during the COVID-19 epidemics in Italy.
Kejžar N; Lusa L
Epidemiol Prev; 2020; 44(5-6 Suppl 2):271-281. PubMed ID: 33412819
[TBL] [Abstract][Full Text] [Related]
38. Spatio-temporal distribution characteristics of COVID-19 in China: a city-level modeling study.
Ma Q; Gao J; Zhang W; Wang L; Li M; Shi J; Zhai Y; Sun D; Wang L; Chen B; Jiang S; Zhao J
BMC Infect Dis; 2021 Aug; 21(1):816. PubMed ID: 34391402
[TBL] [Abstract][Full Text] [Related]
39. Modelling and predicting the spatio-temporal spread of COVID-19, associated deaths and impact of key risk factors in England.
Sartorius B; Lawson AB; Pullan RL
Sci Rep; 2021 Mar; 11(1):5378. PubMed ID: 33686125
[TBL] [Abstract][Full Text] [Related]
40. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study.
Poustchi H; Darvishian M; Mohammadi Z; Shayanrad A; Delavari A; Bahadorimonfared A; Eslami S; Javanmard SH; Shakiba E; Somi MH; Emami A; Saki N; Hormati A; Ansari-Moghaddam A; Saeedi M; Ghasemi-Kebria F; Mohebbi I; Mansour-Ghanaei F; Karami M; Sharifi H; Pourfarzi F; Veisi N; Ghadimi R; Eghtesad S; Niavarani A; Ali Asgari A; Sadeghi A; Sorouri M; Anushiravani A; Amani M; Kaveh S; Feizesani A; Tabarsi P; Keyvani H; Markarian M; Shafighian F; Sima A; Sadjadi A; Radmard AR; Mokdad AH; Sharafkhah M; Malekzadeh R
Lancet Infect Dis; 2021 Apr; 21(4):473-481. PubMed ID: 33338441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
